Natera Reports Q1 2026 Financial Results with Strong Revenue Growth
Natera reported total revenue of $697 million for the first quarter of 2026, reflecting a strong year-over-year growth of 39%. The company processed over one million tests in the quarter and exceeded its gross margin guidance. Key drivers included volume increases across core businesses such as Clinical Oncology and Women's Health.
Tickers: $NTRA
Topics: clinical_oncology gross_margin R&D revenue volume_growth women's_health